Skip to main content

Georgia Marie Beasley, MD, MHS

Assistant Professor of Surgery
Office: Dept of Surgery, Durham, NC 27710
Campus Mail: DUMC Erwin Rd, Durham, NC 27710

Education and Training

  • Surgical Oncology Fellow, Surgery, Ohio State University, 2015 - 2017
  • General Surgery Resident, Surgery, Duke University, 2008 - 2015
  • M.H.S., Duke University, 2012
  • M.D., Duke University School of Medicine, 2008
  • B.A., Duke University, 2001

Publications

Beasley, G. M., A. Selim, N. S. McMahon, A. Coleman, A. P. Abernethy, K. Nelson, S. K. Pruitt, et al. “Prospective Evaluation of PET/CT as a Surveillance Tool to Define Response to Therapy and Identify New Recurrent Disease in Patients with Locally Advanced Melanoma Undergoing Regional Chemotherapy Treatment with Melphalan.” In Annals of Surgical Oncology, 17:S115–S115. SPRINGER, 2010.

Scholars@Duke

Coleman, Andrew, Christina K. Augustine, Georgia Beasley, Gretchen Sanders, and Douglas Tyler. “Optimizing regional infusion treatment strategies for melanoma of the extremities.” Expert Rev Anticancer Ther 9, no. 11 (November 2009): 1599–1609. https://doi.org/10.1586/era.09.126.

Full Text

Beasley, Georgia M., Nicole McMahon, Gretchen Sanders, Christina K. Augustine, Maria A. Selim, Bercedis Peterson, Robin Norris, William P. Peters, Merrick I. Ross, and Douglas S. Tyler. “A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma.” Cancer 115, no. 20 (October 15, 2009): 4766–74. https://doi.org/10.1002/cncr.24509.

Full Text

Santillan, Alfredo A., Keith A. Delman, Georgia M. Beasley, Paul J. Mosca, Steven N. Hochwald, Stephen R. Grobmyer, Robert H. Andtbacka, et al. “Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis.” Ann Surg Oncol 16, no. 9 (September 2009): 2570–78. https://doi.org/10.1245/s10434-009-0563-9.

Full Text

Ceppa, Eugene P., Bantayehu Sileshi, Georgia M. Beasley, and Jeffrey H. Lawson. “Surgical excision of infected arteriovenous grafts: technique and review.” J Vasc Access 10, no. 3 (July 2009): 148–52. https://doi.org/10.1177/112972980901000302.

Full Text

McMahon, N., G. M. Beasley, G. Sanders, C. Augustine, J. Padussis, A. Coleman, M. A. Selim, B. Peterson, M. S. Brady, and D. S. Tyler. “A phase I study of systemic sorafenib in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma.” In Journal of Clinical Oncology, Vol. 27. AMER SOC CLINICAL ONCOLOGY, 2009.

Scholars@Duke

Beasley, G., G. Sanders, J. S. Zager, S. N. Hochwald, S. Grobmyer, R. H. Andtbacka, B. Peterson, W. P. Peters, M. I. Ross, and D. S. Tyler. “A prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion (M-ILI) in patients with advanced extremity melanoma.” In Journal of Clinical Oncology, Vol. 27. AMER SOC CLINICAL ONCOLOGY, 2009.

Scholars@Duke

Bland, Kirby I., Kelly M. McMasters, Roger R. Perry, Edward M. Copeland, and Georgia M. Beasley. “A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the US Discussion.” Journal of the American College of Surgeons 208, no. 5 (May 1, 2009): 715–17.

Scholars@Duke

Beasley, Georgia M., Abigail Caudle, Rebecca P. Petersen, Nicole S. McMahon, James Padussis, Paul J. Mosca, Jonathan S. Zager, et al. “A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.” J Am Coll Surg 208, no. 5 (May 2009): 706–15. https://doi.org/10.1016/j.jamcollsurg.2008.12.019.

Full Text

Pages